Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Rueda Faucz

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of the Endocrine Society|July 1, 2021
The PRKAR1B p.R115K Variant is Associated with Lipoprotein Profile in African American Youth with Metabolic ChallengesMichelle Bloyd, Nikolaos Settas, Fabio Rueda Faucz, et al.
Journal of the Endocrine Society|December 22, 2017
Harvey Cushing Treated the First Known Patient With Carney ComplexCynthia J Tsay, Constantine A Stratakis, Fabio Rueda Faucz, et al.
Stem Cell Research|September 24, 2024
Six induced pluripotent stem cell lines from fibroblasts of individuals with CLN3-related conditionsEwelina Dwojak, Danielle O'Mard, Jizhong Zou, et al.
International Journal of Molecular Sciences|March 13, 2024
Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal HyperplasiaVipula Kolli, Emily Frucci, Isabela Werneck da Cunha, et al.
Human Mutation|April 2, 2010
Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an updateAnélia Horvath, Jérôme Bertherat, Lionel Groussin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2010
Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancerFabio Rueda Faucz, Anelia Horvath, Anya Rothenbuhler, et al.
European Journal of Endocrinology|May 1, 2015
Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentationsMaya B Lodish, Bo Yuan, Isaac Levy, et al.
Cancer Research|June 25, 2009
Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumorsAnelia Horvath, Larissa Korde, Mark H Greene, et al.
Viruses|November 27, 2021
Association between Maternal Non-Coding Interferon-λ Polymorphisms and Congenital Zika Syndrome in a Cohort from Brazilian NortheastÁtila Duque Rossi, Fabio Rueda Faucz, Adriana Melo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2010
Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotypeRossella Libé, Anelia Horvath, Delphine Vezzosi, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of the Endocrine Society|July 1, 2021
The PRKAR1B p.R115K Variant is Associated with Lipoprotein Profile in African American Youth with Metabolic ChallengesMichelle Bloyd, Nikolaos Settas, Fabio Rueda Faucz, et al.
Journal of the Endocrine Society|December 22, 2017
Harvey Cushing Treated the First Known Patient With Carney ComplexCynthia J Tsay, Constantine A Stratakis, Fabio Rueda Faucz, et al.
Stem Cell Research|September 24, 2024
Six induced pluripotent stem cell lines from fibroblasts of individuals with CLN3-related conditionsEwelina Dwojak, Danielle O'Mard, Jizhong Zou, et al.
International Journal of Molecular Sciences|March 13, 2024
Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal HyperplasiaVipula Kolli, Emily Frucci, Isabela Werneck da Cunha, et al.
Human Mutation|April 2, 2010
Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an updateAnélia Horvath, Jérôme Bertherat, Lionel Groussin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2010
Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancerFabio Rueda Faucz, Anelia Horvath, Anya Rothenbuhler, et al.
European Journal of Endocrinology|May 1, 2015
Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentationsMaya B Lodish, Bo Yuan, Isaac Levy, et al.
Cancer Research|June 25, 2009
Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumorsAnelia Horvath, Larissa Korde, Mark H Greene, et al.
Viruses|November 27, 2021
Association between Maternal Non-Coding Interferon-λ Polymorphisms and Congenital Zika Syndrome in a Cohort from Brazilian NortheastÁtila Duque Rossi, Fabio Rueda Faucz, Adriana Melo, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2010
Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotypeRossella Libé, Anelia Horvath, Delphine Vezzosi, et al.
Pageof 3